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A variety of polypeptide growth factors are involved in the dynamic maintenance of the skin and hair. Here, we
demonstrate the presence of high levels of ﬁbroblast growth factor (FGF)-13 in the bulge region of hair follicles.
Using real-time PCR, we found that expression of FGF-13 mRNA is comparable to, or higher than, that of other FGF
known to regulate hair growth and wound healing. To gain additional insight into the function of FGF-13, we
evaluated its distribution using in situ hybridization and immunohistochemical staining. Unlike other FGF, the
distribution of FGF-13 mRNA and protein in adult mice was mainly restricted to cells in the bulge region of hair
follicles, although lower levels were detected with less frequency in keratinocytes in the basal layer of the
epidermis. FGF-13 protein was detectable in the bulge region throughout the hair growth cycle, but its distribution
was especially wide during telogen and early anagen. During hair follicle morphogenesis in newborn mice, FGF-13
protein was ﬁrst detected in the bulge region and basal layer keratinocytes 3 d after birth. These ﬁndings suggest
that FGF-13 may play a role in regulating the function of cells in the bulge region and basal layer of the epidermis.
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The fibroblast growth factor (FGF) family of ligands is
encoded by 22 distinct genes in mice and humans (Ornitz
and Itoh, 2001), whereas four genes encode transmem-
brane FGF receptor (FGFR) tyrosine kinases (Jaye et al,
1992). Moreover, both the ligand and receptor gene
products are subject to mRNA splicing variations and
post-translational changes in their binding specificities
and affinities. The result is a large group of ligands and
receptors that, in combination, mediate a wide variety of
biological activities. Among them, FGF-1, -2, -5, -7, -10, and
-22 are known to be expressed in dermal and hair follicular
cells and to regulate the hair growth and skin regeneration
(Diana and DuCros, 1993; DuCros, 1993; DuCros et al,
1993; Hebert et al, 1994; Danilenko et al, 1995; Marchese
et al, 1995; Guo et al, 1996; Petho-Schramm et al, 1996;
Rosenquist and Martin, 1996; Mitsui et al, 1997; Ortega
et al, 1998; Suzuki et al, 2000; Nakatake et al, 2001; Stenn and
Paus, 2001; Beyer et al, 2003). FGF-7, -10, and -22 function
in concert with the FGFR-2 IIIb to stimulate proliferation of
keratinocyte in the normal and wounded skin (Werner et al,
1994; Marchese et al, 1995; Igarashi et al, 1998; Ohuchi et al,
2000; Beyer et al, 2003). Collectively, these studies clearly
demonstrate the importance of the concerted activities of
FGF in the skin. Yet the expression levels of these molecules
in the skin have never been systemically compared or
quantified. In this study, therefore, we established an
experimental system with which to quantify levels of FGF
mRNA expression. This approach enabled us to show for
the first time that FGF-13 (FHF-2: Smallwood et al, 1996) is
specifically expressed in the cells of the bulge region of hair
follicles and in the basal layer of the epidermis, suggesting
its possible role in regulating the function of those cells.
Results
High levels of FGF-13 mRNA are expressed in murine
skin Previous studies have shown that FGF-1, -2, -5, -7,
-10, and -22 are all highly expressed in the skin and play
important roles in the skin and/or hair dynamics (DuCros
et al, 1993; Hebert et al, 1994; Danilenko et al, 1995; Guo
et al, 1996; Rosenquist and Martin, 1996; Mitsui et al, 1997;
Ortega et al, 1998; Nakatake et al, 2001; Beyer et al, 2003).
Using RT-PCR, we discovered that FGF-13 mRNA is also
expressed in the skin (Fig 1A, arrow). As expression of FGF-
13 in the skin has not been studied previously, we first
established an experimental system to quantitate FGF-13
expression and compare it with that of other FGF involved in
hair growth and wound healing. This entailed designing a
set of highly specific primers and using real-time PCR to
measure the absolute copy number of the mRNA. In this
analysis, cloned cDNA fragments served as references for
copy number (Suzuki M, et al, unpublished data). We found
that on day 8 of the hair cycle, the level of FGF-13
expression was high, about 1500 copies/20 ng total RNA,
which was similar to the levels of FGF-5 (including two
forms of FGF-5 mRNA; Ozawa et al, 1998), -7, -10, and -22,
and higher than the levels of FGF-1 (or acidic FGF) and -2
Abbreviations: FGF, fibroblast growth factor; FHF, FGF homolo-
gous factor; PBS, phosphate-buffered saline; SSC, standard saline
citrate
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(or basic FGF) (Fig 1B). Moreover, using RT-PCR to quantify
FGF-13 mRNA expression over the course of the hair cycle,
we found that the transcript was most abundant during
telogen (days 0 and 22) and early anagen (days 3 and 5) and
less so during mid-late anagen (days 8 and 18) (Fig 1C).
In situ hybridization shows bulge- and basal layer-
speciﬁc expression of FGF-13 mRNA To gain additional
insight into the function of FGF-13 in murine skin, we next
determined its distribution using in situ hybridization and
immunohistochemical analysis. Although the focus of this
study was on FGF-13, for comparison we also examined the
expression of FGF-1 mRNA, which has been well char-
acterized (DuCros et al, 1993). In mid-anagen (anagen V;
day 8 after dipilation), FGF-13 mRNA expression was largely
limited to the bulge region of hair follicles (Fig 2A; arrows).
This expression pattern was clearly different from that of
FGF-1 (Fig 2C). As previously reported (DuCros et al, 1993),
FGF-1 was much more widely distributed in the hair bulb,
especially in the inner root sheath cells (Fig 2C; arrow)
and in dermal papilla. The sense probes produced no signal
(Fig 2B and D).
Speciﬁcity of the immunohistochemical staining of
FGF-13 To analyze the distribution of FGF-13 protein in
the skin, we initially verified the specificity of the anti-FGF-
13 antibody used for immunohistochemical staining. Mid-
anagen skin (day 8 after dipilation) was used for this
purpose because each portion of the hair follicle––that is,
the permanent portion, bulge region, and transient por-
tion—can be readily resolved at this stage. Consistent with
the in situ hybridization, FGF-13 protein was detected
Figure 1
High levels of FGF-13 mRNA are expressed in mouse skin. (A) A
portion of the dorsal skin of five C3H/HeN male mice was depilated
during telogen (at 8 wk of age). Eight days later (anagen V phase of
the hair cycle), the skin samples were harvested and total RNA was
extracted. After reverse transcription using (dT)1218 as a primer, the
cDNA pool was amplified with specific primers for FGF-13. The PCR
reaction product was run on an agarose gel and photographed; M, 100-
bp ladder markers. The arrow indicates the amplified fragment of FGF-
13 cDNA. (B) The cDNA from the skin sample in panel A was amplified
with specific primers for various FGF members. With the aid of serial
dilutions of standard plasmids, absolute copy numbers for each FGF
were calculated. Bars represent mean  SD of results obtained from
five mice. (C) A portion of the dorsal skin of C3H/HeN male mice was
depilated during telogen (at 8 wk of age) and then at selected times
thereafter (various stages of the hair cycle), the skin samples were
harvested. Total RNA was extracted and further purified to mRNA, after
which reverse transcription and quantification of the FGF-13 mRNA
was carried out as in panel B.
Figure2
Localization of FGF-13 mRNA in the bulge region of the anagen
hair follicle. A portion of the dorsal skin of C3H/HeN mice was
depilated during telogen phase (8-wk old), and 8-d later skin samples
were isolated from the same area, frozen and sectioned. In situ
hybridization was carried out using digoxygenin-labeled antisense
riboprobes specific for FGF-13 (A) or FGF-1 (C); the arrows indicate the
respective signals. As a control, the respective sense probes (B and D,
respectively) were also prepared and used for hybridization. The bound
riboprobe was detected with anti-digoxygenin antibody conjugated
with alkaline-phosphatase; the signals were visualized using BM Purple
(purple signals). Bars, 100 mm.
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mainly in the bulge region of the hair follicles (Fig 3A, arrow
and B). No labeling was observed in the hair bulb, dermal
papilla, inner root sheath, or general outer root sheath,
except in the bulge region (Fig 3A). The intense labeling in
the bulge region was confirmed to be specific for FGF-13,
as it was not observed when sections were stained with the
same antibody in the presence of excess (approx. 10,000-
fold molar concentration) epitope peptide (Fig 3C), or when
non-immune (normal) rabbit serum was used as the primary
antibody (Fig 3D).
Immunohistochemical staining shows bulge- and basal
layer-speciﬁc expression of FGF-13 protein throughout
the hair cycle in adult mice Once the specificity of the
antibody was confirmed, we examined the distribution of
FGF-13 protein at selected stages during the hair cycle in
adult mice, that is, anagen II, III, V, and VI (days 3, 5, 8, and
18 after depilation, respectively), catagen IV (day 20 after
dipilation), and telogen (days 0 and 22 after depilation).
Interestingly, we found it to be present throughout the cycle,
mainly in the bulge region (Fig 4A–I ). Especially wide
distributions of staining were observed during telogen (day
0, Fig 4A; day 22, Fig 4G and H) and early anagen (day 3,
Fig 4B and I; day 5; Fig 4C); during telogen, cells located at
the bottom part of the retarded hair follicles––that is, in the
bulge region––were intensely stained for FGF-13. Further
examination of the day-22 skin revealed FGF-13-positive
cells to be distributed in the inner and outer parts of the
bulge region during telogen (Fig 4H ).
We found that some cells in the basal layer of the
epidermis also harbored the protein (Fig 4J–N ), although
the signal was weaker and appeared less frequently than in
the bulge region.
Expression of FGF-13 protein during hair follicle
morphogenesis in newborn mice Finally, we examined
expression of FGF-13 protein during hair follicle morpho-
genesis in 1-, 3-, 7-, 13-, 16-, and 18-d-old mice (Fig 5).
Little or no FGF-13 was detected in the skin of 1-d-old mice
(hair follicles of stages 3–5; Paus et al, 1999) (Fig 5A), and
only weak labeling of FGF-13 was detected in the bulge
region of 3 (stages 4–8)- and 7 (stage 8 and later)-d-old
mice (Fig 5B and C). By day 13 and later (days 13, 16,
and 18), however, the labeling of FGF-13 had become
very intense in both the bulge region and basal layer of
the epidermis (Fig 5D–F ). Moreover, we noted that the
distribution of FGF-13-positive cells in the basal layer of
the epidermis was more apparent in newborn mice than in
adult mice.
Discussion
We have shown that throughout the hair cycle of adult mice,
FGF-13 is specifically distributed in the bulge region of the
follicle and the basal layer of the epidermis. During hair
follicle morphogenesis in newborn mice, the presence of
FGF-13 protein in these regions was first detected 3 d after
birth (stages 4–8) and became apparent about 7 d after birth
(stage 8 and later). Although characterization of FGF-13’s
activity in the skin has not been completed, these findings
suggest that FGF-13 may play a role in regulating the
function of the cells in the bulge region and in the basal layer
of the epidermis.
Although there have been studies of the expression and
activity of other FGF in dermal cells and hair follicles
(DuCros et al, 1993; Hebert et al, 1994; Danilenko et al,
1995; Guo et al, 1996; Rosenquist and Martin, 1996; Mitsui
Figure 3
Specificity of the anti-FGF-13 antibody used for immunohisto-
chemical staining. (A, B) To examine the region- and epitope-specific
labeling of FGF-13, skin samples harvested from five C3H/HeN mice
during the anagen V phase of the hair cycle (day 8 after dipilation) were
fixed in formalin, embedded in paraffin, sliced into 4-mm sections, and
labeled with the rabbit anti-FGF-13 antibody (diluted 1:1000) generated
as described in Materials and Methods. The bound antibody was
detected with biotinylated goat anti-rabbit IgG (diluted 1:100), and the
signals were visualized using a HISTOSTAIN-SP kit (brown red signals).
The sections were counterstained with hematoxylin. (A) Representative
labeling of FGF-13 protein in the entire hair follicle at anagen V (day 8).
The image is a composite of three micrographs taken at high
magnification (  40 objective lens). (B) Labeling of FGF-13 protein
around the bulge region. (C) Labeling in the presence of excess epitope
peptide. This skin section was incubated with rabbit anti-FGF-13 in
the presence of excess epitope peptide (approx. 10,000-fold molar
concentration) and processed as in panel A. (D) Control labeling. This
skin section was incubated with normal rabbit serum and processed as
in the other panels. Bars, 100 mm.
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et al, 1997; Ortega et al, 1998; Nakatake et al, 2001; Beyer
et al, 2003), ours is the first description of FGF-13 expres-
sion in the skin.
Within the skin, FGF-1 is expressed in inner root sheath
cells and other follicular cells and appears to induce cells to
secrete growth promoting factors for outer root sheath cells
(Ota et al, 2002). FGF-2 is also expressed in inner root
sheath cells and stimulates the proliferation of hair follicle
cells (Mitsui et al, 1997); moreover, during wound healing it
stimulates proliferation of dermal fibroblasts (Ortega et al,
1998). Both translation products of Fgf-5 gene, FGF-5 and
FGF-5S (Ozawa et al, 1998), play important roles in the
regulation of the anagen phase and the onset of the cata-
gen phase during the hair cycle (Suzuki et al, 1998, 2000).
FGF-7, -10, and -22 are specific ligands for a keratinocyte-
specific form of FGFR (FGFR2 IIIb) and stimulate keratino-
cyte proliferation for wound healing (Guo et al, 1996; Beyer
et al, 2003). Thus, by acting on different cell types under
specific sets of conditions, FGF appear to regulate the hair/
skin system dynamically.
The function of FGF-13 in the bulge region and in the
basal layer of the epidermis is not yet known. As its
expression was not observed in the temporary portion of
the anagen hair follicle, FGF-13 may play a role in the
regulation of keratinocytes committed to the epidermis. If
so, FGF-13 may be a useful marker of epidermal keratino-
cyte stem cells and their progeny (Taylor et al, 2000). During
embryonic organogenesis, FGF-13 is known to be involved
in development of the nervous system and heart, where its
expression pattern suggests that it performs functions
distinct from other known FGF (Hartung et al, 1997). FGF-
13 is also expressed in the brains and hearts of adults, but
the levels are significantly lower than in other tissues (e.g.,
the kidney and ovary) (Hartung et al, 1997), which suggests
that expression may correlate with stem cell activity in the
expressing organ.
As a member of FGF family, FGF-13 may exert its effects
through actions on one or more of the FGFR tyrosine
kinases. At present, however, the binding specificity of FGF-
13 is not known. Alternatively, it is also possible that FGF-13
acts via as yet uncharacterized pathways––for example, by
recruiting intracellular binding proteins (Smallwood et al,
1996; Schoorlemmer and Goldfarb, 2001), or by binding to
scaffold proteins, as do FGF-12 (or FHF-1) and FGF-14 (or
FHF-4) (Olsen et al, 2003); like FGF-1, -2, -11, -12, and -14;
FGF-13 lacks a secretion signal peptide. Finally, FGF-13
may be inefficiently exported from cells, despite the
Figure4
Localization of FGF-13 protein in adult mice during various stages
of the hair cycle. Skin samples from C3H/HeN mice harvested at
various stages of the hair cycle were fixed in formalin, embedded in
paraffin, cut into 4-mm-thick sections, and analyzed for FGF-13 pro-
tein as in this figure. Five mice were examined at each stage, and
representative results are shown. (A–I) Hair follicles: (A) telogen skin
(day 0); (B) anagen II skin (day 3); (C) anagen III skin (day 5); (D) anagen
V skin (day 8); (E) anagen VI skin (day 18); (F) catagen IV skin (day 20).
(G, H) Telogen skin (day 22): (G) the open arrow indicates FGF-13-
positive cells located between the bulge region and the epidermis; (H)
hair follicles were cut into round slices and immunostained for FGF-13.
(I–N) Epidermis: (I) anagen II skin (day 3); (J) anagen III skin (day 5);
(K) anagen V skin (day 8); (L) anagen VI skin (day 18); (M) catagen IV
skin (day 20); (N) telogen skin (day 22). Bars, 100 mm.
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absence of a signal peptide, in a manner similar to FGF-1
(Landriscina et al, 2001) or FGF-2. In any case, it appears to
us that the likely targets of FGF-13 are the expressing cells
themselves or those nearby. All these questions await
further investigation.
Materials and Methods
Mice and skin sample preparation Throughout this study, all
animals received humane care that was in accordance with the
guidelines of AIST. All protocols were approved by the animal
experiment committee of AIST. For hair cycle experiments, 35 7-
wk-old male C3H/HeN mice (Tlr4þ /þ ) were obtained from Japan
SLC (Hamamatsu, Japan) and maintained on a standard laboratory
diet and water ad libitum. After conditioning for 1 wk, five mice
were euthanized, the dorsal hair was cut short, and the skin
samples were isolated and examined as the ‘‘day 0 (telogen)’’
sample. In the remaining 30 mice, the anagen phase of the hair
growth cycle was induced by gently depilating their dorsal hair
shafts manually without using wax or dipilatory chemicals. Then, at
selected stages of hair follicle transformation––that is, on days 3
(anagen II), 5 (anagen III), 8 (anagen V), 18 (anagen VI), 20 (catagen
IV), and 22 (telogen) after depilation––the mice were euthanized,
and the skin samples were isolated from the depilated area
and processed for either mRNA isolation, in situ hybridization, or
immunohistochemical staining. Five mice were examined for each
stage of hair follicle transformation. The experiment was then
carried out once again using essentially the same design to confirm
the reproducibility of the results.
For hair morphogenesis studies, the dorsal skin samples were
isolated from untreated newborn C3H/HeN mice (male and female)
on days 1 (stages 3–5), 3 (stages 4–8), 7 (stage 8 and later), 13, 16,
and 18 after birth, examined and processed for immunohisto-
chemical staining. At least five mice were examined at each stage
of hair morphogenesis. For in situ hybridization, the skin samples
were immediately frozen in optimal cutting temperature (OCT)
compound using liquid nitrogen. For immunohistochemical staining,
the samples were first fixed for 24 h at room temperature in 10%
formaldehyde and then embedded in paraffin using standard pro-
cedures (Suzuki et al, 1998).
mRNA preparation and reverse transcription Total RNA was
prepared from the skin samples using Isogen (Nippon Gene, Tokyo,
Japan) according to the manufacturer’s instructions. In some
cases, the mRNA was purified from the total RNA using an
Oligotex-dT30 Super mRNA purification kit (Takara Bio Inc., Osaka,
Japan). Samples of the isolated RNA (2 mg of total RNA or 100 ng of
mRNA) were then reverse-transcribed in a total volume of 20 mL
Figure 5
Localization of FGF-13 protein in newborn
mice during hair follicle morphogenesis.
Dorsal skin samples from C3H/HeN newborn
mice were harvested on days 1, 3, 7, 13, 16, and
18 after birth. The samples were processed and
analyzed for FGF-13 protein as in Fig 3.
Representative distribution of FGF-13 protein in
1-d (A: stage 3–5)-, 3-d (B: stage 4–8)-, 7-d
(C: stage 8 and later)-, 13-d (D)-, 16-d (E)-, and
18-d (F)-old skin. Bars, 100 mm.
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using SuperScript II with Oligo (dT)1218 as a primer (Gibco BRL,
Tokyo, Japan).
Design of PCR primers and cloning of cDNAs for FGF-13 and
other FGF family members Specific primer sets were designed
so that the levels of FGF mRNA could be quantitatively analyzed
using real-time PCR. The same sets of primers were also used for
cloning respective cDNA fragments for use as copy number
references in the quantification. The primers used for FGF-13 am-
plification were 50-GGCAATGAACAGCGAGGGATACTTGTACAC-30
(sense) and 50-CGGATTGCTGCTGACGGTAGATCATTGATG-30 (an-
tisense). The RT mixture was diluted 10 times with dH2O, after
which PCR amplification was carried out using Pfu polymerase
according to the manufacturer’s (Stratagene, La Jolla, California,
USA) instructions. After PCR, aliquots of the reaction solution were
run on 2.0% agarose gels to confirm the size of the amplified
products. To clone the respective cDNAs, the PCR products were
ligated into pCR-Blunt II-TOPO vector (Invitrogen, Carlsbad,
California, USA), which was then used to transform Escherichia
coli. The nucleotide sequences of the recombinant plasmids were
verified using a BigDye terminator cycle sequencing kit and an ABI
PRISM 310 Genetic Analyzer (Applied Biosystems, Foster city,
California, USA).
Quantiﬁcation of mRNA copy number by real-time PCR Real-
time PCR amplification was carried out in a Light Cycler (Roche
Diagnostics, Basel, Switzerland). Two mL of the 1:10 diluted RT pro-
duct was used as a template. To obtain the absolute copy numbers
of each FGF, plasmid DNAs for each FGF were used for copy
number references. After the quantification procedure, the yielded
products were resolved by 2.0% agarose gel electrophoresis to
confirm that the reaction had amplified the right DNA fragments.
In situ hybridization The in situ hybridization experiments were
performed using OCT-embedded frozen tissue sections and
digoxygenin-labeled riboprobes essentially as described pre-
viously (Komminoth, 1992). Sense and antisense riboprobes were
synthesized using SP6 and T7 RNA polymerases, respectively,
in the presence of digoxygenin-dUTP (Roche Applied Science,
Mannheim, Germany).
All possible effort was made to avoid RNA degradation during
the hybridization procedure. The frozen tissues were cut into 10-mm
sections using a Cryostat (Microm, model HM500OM Microm
International GmbH, Walldorf, Germany), immediately placed on
slide glasses and dried at 501C for 1 h, and then stored at 801C
with a desiccant. Before hybridization, sections were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 10 min at
room temperature and then washed with PBS for 5 min. Thereafter,
the sections were permeabilized with proteinase K (0.01 mg per mL
in  2 TE 10 mM Tris-Hcl, 1 mM EDTA, pH8.0 (TE)) for 5 min at 371C,
rinsed with PBS, again fixed with 4% paraformaldehyde in PBS for
5 min, and washed with PBS for 5 min. The fixed sections were
methylated by soaking them twice in 0.1% diethylpyrocarbonate
in PBS for 15 min each, rinsed with PBS, and soaked in
 5 saline-sodium citrate (SSC) for 15 min. Finally, hybridization
was carried out for 16–18 h at 581C using 500 ng per mL of heat-
denatured (701C for 10 min) probe in 100 mL of hybridization buffer
consisting of 50% (vol/vol) formamide,  5 SSC, 500 mg per mL
salmon testes DNA, 250 mg per mL t-RNA,  5 Denhardt’s
solution and 1 mM dithiothreitol (DTT). After hybridization, the
slides were rinsed and washed with  2 SSC for 30 min at room
temperature, with  2 SSC at 651C for 20 min, and then three
times with  0.1 SSC at 651C for 20 min. The bound riboprobe
was detected with anti-digoxygenin antibody conjugated with
alkaline-phosphatase (1:500, Roche). For visualization, a colori-
metric reaction with nitro-blue tetrazolium and 5-bromo-4-chloro-
3-indolyl-1-phosphate (NBT/BCIP) was carried out using BM
Purple (Roche) for 72–75 h at room temperature in the dark.
Immunohistochemical staining Immunohistochemical analysis
was carried out using paraffin-embedded tissue sections with
anti-FGF-13 antibody. The antibody was generated in rabbits
injected with a mouse FGF-13 fragment conjugated with Keyhole
Limpet hemocyanin (KLH). After evaluating the titer of this antibody
using an enzyme-linked immunosolvent assay (results not shown),
we confirmed the specificity by immunoblotting. We found that this
antibody specifically recognized FGF-13 among a large number of
unrelated proteins also present in the in vitro translation mixture
(see Fig 6).
Formalin-fixed mouse skin samples were sliced into 4-mm
sections, placed on slide glasses, and deparaffinized. The skin
sections were then subjected to antigen retrieval by soaking them
for 2 min in boiled 0.01 M citrate adjusted to pH 6.0, after which
they were blocked with 10% normal goat serum and incubated
with anti-FGF-13 rabbit antiserum (1:1000 dilution) or the same
dilution of non-immune rabbit serum for 2 h at room temperature.
After washing three times with PBS for 2 min with shaking, the
sections were incubated with biotinylated goat anti-rabbit IgG
(Santa Cruz Biotechnology, Inc., Santa Cruz, California, USA; 1:100
dilution) for 10 min at room temperature, and the signals were
visualized using a HISTOSTAIN-SP kit according to the manufac-
turer’s (Zymed Laboratories Inc, San Francisco, California, USA)
instructions. Aminoethylcalbazole (red) served as the chromogen;
the sections were counterstained with hematoxylin (blue). In each
experiment, we stained at least five slides for every stage of the hair
cycle. The experiments were repeated at least twice to confirm that
the results were reproducible.
In vitro translation and immunoblotting In vitro translation of
FGF-13 was carried out using a Puresystem Classic Mini kit (Post
Genome Institute, Tokyo, Japan) according to the manufacturer’s
instructions. Briefly, the template cDNA to be translated was
prepared by subjecting it to PCR using a protocol that incorporated
the T7 promoter. It was then translated in a reaction mixture
containing all the factors necessary for transcription/translation. As
a control, the reaction was carried out without a template. After
termination of the reaction, the mixture was resolved by SDS-15%
polyacrylamide gel electrophoresis, transferred to a nitrocellulose
membrane, and blotted with the anti-FGF-13 antiserum (1:500
dilution). The signal was visualized using enhanced chemilumines-
cence (ECL)-western blotting detection reagents (Amersham Bio-
sciences, Buckinghamshire, UK) and X-O mat XB-1 film (Kodak,
Rochester, New York, USA).
Figure6
Specificity of the anti-FGF-13 antibody. In vitro translation of FGF-13
was carried out. As a control, the reaction was run without target
template DNA. After termination of the reaction, the mixture, which
contained a variety of proteins involved in transcription/translation, was
resolved by SDS-polyacrylamide gel electrophoresis. The resolved
proteins were either stained with CBB dye, or further transferred to a
nitrocellulose membrane, and immunoblotted with the anti-FGF-13
antibody. The signal was visualized using ECL-western blotting detec-
tion reagents.
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